학술논문
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
Document Type
Article
Author
Guglielmetti, L.; Atger, M.; Bonnet, M.; Cloez, S.; Delifer, C.; Ducher, V.; Lachenal, N.; Mazmanian, M.; Moschioni, M.; Pichon, L.; Varaine, F.; Ardizzoni, E.; de Jong, B.C.; Rupasinghe, P.; Baudin, E.; Tozzi, D.D.S.; Gouillou, M.; Berikova, E.; Chang, E.; Coit, J.M.; Do, J.M.; LaHood, A.N.; Lecca, L.; Rich, M.L.; Seung, K.J.; Velásquez, G.E.; Mitnick, C.D.; Cox, V.; Ferlazzo, G.; Khan, A.; Khan, U.; McIlleron, H.; O’Brien, K.; Okunbor, O.; Oyewusi, L.; Tamirat, M.; Panda, S.; Patil, S.B.; Phillips, P.P.J.; Saluhuddin, N.; Trippa, L.; Cellamare, M.; Wasserman, S.; Zimetbaum, P.J.
Source
In: Trials . (Trials, December 2021, 22(1))
Subject
Language
English
ISSN
17456215